Calcium Channel Blockers
Start with the big picture
Dihydropyridines such as amlodipine and nifedipine act mainly on vascular smooth muscle, producing arteriolar vasodilation. Non-dihydropyridines, including verapamil and diltiazem, have greater effects on the SA and AV nodes and myocardium, slowing heart rate and conduction and reducing contractility. CCBs are used for essential hypertension and also have roles in conditions such as angina and arrhythmias; specific agents have additional uses. Their different actions inform their adverse-effect profiles: edema and flushing are associated with dihydropyridines, while non-dihydropyridines may cause bradycardia, AV block, constipation, or worsening heart failure. The full topic also addresses interactions, contraindications, overdose management, and withdrawal considerations.
What you'll learn
- Distinguish dihydropyridine and non-dihydropyridine CCBs by their principal sites of action.
- Explain how L-type calcium channel blockade affects vascular tone and cardiac function.
- Relate common CCB adverse effects to their pharmacologic actions.
- Identify important clinical uses, precautions, and interaction considerations for CCBs.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.